Air Lease: Q2 Earnings Snapshot
The Los Angeles-based company said it had profit of $3.33 per share. Earnings, adjusted for one-time gains and costs, came to $1.40 per share.
The company that leases planes to airlines posted revenue of $731.7 million in the period.
Air Lease shares have climbed 14% since the beginning of the year. In the final minutes of trading on Monday, shares hit $55.15, an increase of 34% in the last 12 months.
_____
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
11 minutes ago
- Business Upturn
Aurobindo Pharma share: HSBC, Motilal Oswal, Nuvama maintain ‘Buy'; Avendus retains ‘Reduce' as brokerages assess US outlook and margin risks
Shares of Aurobindo Pharma have drawn mixed reactions from top brokerages following its recent earnings performance. While HSBC, Motilal Oswal, and Nuvama continue to maintain a 'Buy' rating, Avendus has retained a more cautious 'Reduce' stance, citing near-term margin and execution risks in the US segment. Motilal Oswal on Aurobindo Pharma share: Maintains 'Buy', TP cut to ₹1,300 Motilal Oswal Financial Services has maintained its 'Buy' rating on Aurobindo Pharma but lowered the target price to ₹1,300 from ₹1,365. The brokerage noted strong growth in the EU and ARV segments but flagged continued margin pressure as a drag on profitability. EBITDA margin guidance remains unchanged at 20–21% for FY26. Motilal is optimistic about the Lanett acquisition improving profitability and expects the company to file its first US biosimilar in FY26. Earnings estimates for FY26/FY27 were cut by 8%/7% due to pricing headwinds and startup costs at Pen-G and China units. Avendus on Aurobindo Pharma share: Maintains 'Reduce', TP cut to ₹1,145 Avendus has reiterated its 'Reduce' rating with a revised target price of ₹1,145, down from ₹1,220. The firm expects US sales (excluding gRevlimid) to grow at a 9% CAGR over FY25–27E, driven by recovery in injectables and oral solids. EU revenues are expected to grow at a 14% CAGR, aided by new launches and China/Vizag-based supplies. However, the brokerage expressed concerns over delays in monetizing complex assets such as biosimilars and LA injectables, which are now expected to contribute meaningfully only post-FY28. Avendus projects a 15% EPS CAGR (ex-gRevlimid and Pen-G) through FY27 and sees the Lanett acquisition turning EPS-neutral by FY27. EPS estimates have been revised down by 9%/7% for FY26/FY27 due to lower sales and margin risks. HSBC on Aurobindo Pharma share: Maintains 'Buy', TP cut to ₹1,255 HSBC continues to maintain a 'Buy' call on Aurobindo Pharma, cutting its target price to ₹1,255. The brokerage flagged a Q1 miss driven by weaker-than-expected gRevlimid sales, US channel destocking, and pricing pressure in the API business. It highlighted Europe as a bright spot in the company's portfolio. HSBC remains constructive on future margin support from new plant supplies (Pen-G, Vizag, China) and expects volume-led growth to sustain. The brokerage is also watching for closure on the Lanett portfolio acquisition, which could add to long-term growth momentum. Nuvama on Aurobindo Pharma share: Maintains 'Buy', TP reduced to ₹1,445 Nuvama Institutional Equities has also maintained its 'Buy' rating while trimming the target price slightly to ₹1,445 from ₹1,460. The firm highlighted that gross margins remained resilient despite a decline in gRevlimid contributions. Ex-gRevlimid EBITDA margins expanded ~100 bps YoY. Key near-term triggers include the ramp-up of Pen-G and China units, MIP implementation, closure of the Lanett acquisition, and new injectable filings. Nuvama has trimmed its FY27E EPS forecast by around 2%, factoring in near-term execution risks. With varying degrees of optimism, brokerages remain focused on Aurobindo's US trajectory, biosimilar launches, and integration of recent acquisitions as key determinants of its medium-term growth story. Disclaimer: The views and investment recommendations expressed in this article are those of the respective brokerages. These do not represent the views of Business Upturn and do not constitute investment advice. Investors are advised to consult their financial advisors before making any investment decisions. Ahmedabad Plane Crash Arunika Jain, a graduate in Mass Communication, brings a fresh perspective to the world of journalism. Arunika has a passion for writing finance and corporate news at You can write to her at [email protected]
CNBC
an hour ago
- CNBC
Two Chinese nationals charged for illegally shipping Nvidia AI chips to China
Two Chinese nationals in California have been arrested and charged with the illegal shipment of tens of millions of dollars' worth of AI chips, the Department of Justice said Tuesday. Chuan Geng, 28, and Shiwei Yang, 28, exported the sensitive chips and other technology to China from October 2022 through July 2025 without obtaining the required licenses, the DOJ said, citing an affidavit filed with the complaint. The illicit shipments included Nvidia's H100 general processing units, according to the affidavit seen by Reuters. The H100 is amongst the U.S. chipmaker's most cutting-edge chips used in artificial intelligence allocations. The Department of Commerce has placed such chips under export controls since 2022 as part of broader efforts by the U.S. to restrict China's access to the most advanced semiconductor technology. This case demonstrates that smuggling is a "nonstarter," Nvidia told CNBC. "We primarily sell our products to well-known partners, including OEMs, who help us ensure that all sales comply with U.S. export control rules." "Even relatively small exporters and shipments are subject to thorough review and scrutiny, and any diverted products would have no service, support, or updates," the chipmaker added. Geng and Yang's California-based company, ALX Solutions, had been founded shortly after the U.S. chip controls first came into place. According to the DOJ, law enforcement searched ALX Solutions' office and seized the phones belonging to Geng and Yang, which revealed incriminating communications between the defendants, including communications about evading U.S. export laws by shipping the export-controlled chips to China through Malaysia. The review also showed that in December 2024, ALX Solutions made over 20 shipments from the U.S. to shipping and freight-forwarding companies in Singapore and Malaysia, which the DOJ said are commonly used as transshipment points to conceal illicit shipments to China. ALX Solutions did not appear to have been paid by entities they purportedly exported goods to, instead receiving numerous payments from companies based in Hong Kong and China. The U.S. Department of Commerce's Bureau of Industry and Security and the FBI are continuing to investigate the matter. The smuggling of advanced microchips has become a growing concern in Washington. According to a report from the Financial Times last month, at least $1 billion worth of Nvidia's chips entered China after Donald Trump tightened chip export controls earlier this year. In response to the report, Nvidia had said that data centers built with smuggled chips were a "losing proposition" and that it does not support unauthorized products.
Yahoo
2 hours ago
- Yahoo
Trump's pursuit of meeting with Chinese leader reveals the complex web of US-China relations
WASHINGTON (AP) — China, the adversary. China, the friend? These days, maybe a bit of both. From easing export controls to reportedly blocking the Taiwanese president's plans to travel through the United States, President Donald Trump is raising eyebrows in Washington that he might offer concessions that could hurt U.S. interests in his quest to meet, and reach a deal with, the Chinese leader. There is no firm plan for Trump to meet Chinese President Xi Jinping. But it's widely believed that the men must meet in person, likely in the fall, for the two governments to ink a trade deal, and some are worried that Xi is leveraging Trump's desire for more giveaways. "The summit mismatch is real. There's a clear gap between Trump's eagerness for a face-to-face with Xi and Beijing's reluctance to engage," said Craig Singleton, senior director of the China program at the Washington-based think tank Foundation for Defense of Democracies. There are concerns that Trump may throttle back on export controls or investment curbs to preserve summit prospects, Singleton said, warning the risk 'isn't just in giving away too much' but also "in letting Beijing set the tempo.' China-U.S. relations have pinballed often since Washington established relations with communist-led Beijing in 1979. They've hit highs and lows — the latter in the aftermath of the 1989 massacre of pro-democracy protesters in Tiananmen Square, after a 2001 incident involving a U.S. spy plane, during the COVID pandemic and right now. Both countries have struggled to understand each other, which has sometimes gotten in the way of deeper partnerships. And this time around, there's a wild card: the anything-might-happen second presidency of Trump. Disputes often accompany potential US-China leader meetings Efforts by a U.S. president to meet the head of the authoritarian Chinese government have often met with partisan outcries — which happened when former President Joe Biden hosted Xi in California in 2023. But Trump's case is peculiar, partly because he is willing to break with conventional political restraints to make deals and partly because his own party has grown hawkish towards China over national security. 'With President Trump, everything seems to be open for negotiation, and there are few if any red lines,' said Gabriel Wildau, managing director of the global consultancy Teneo. 'The hawks worry that if Trump gets into a room with Xi, he will agree to extraordinary concessions, especially if he believes that a big, beautiful deal is within reach.' While most Republican lawmakers have not voiced their concerns openly, Democrats are vocal in their opposition. "President Trump is giving away the farm to Xi just so he can save face and reach a nonsensical trade deal with Beijing that will hurt American families economically," said Rep. Gregory Meeks, the top Democrat on the House Foreign Affairs Committee. On Tuesday, Kush Desai, a White House spokesman, said the Trump administration 'has not wavered — and will never waver — in safeguarding our national and economic security to put America first.' 'The administration continues to have productive conversations with China to address longstanding unfair trade practices,' Desai said, adding that export controls on cutting-edge technology and many tariffs remain in place. Treasury Secretary Scott Bessent, after his latest round of trade negotiations with the Chinese in July, told CNBC that the team was 'very careful to keep trade and national security separate.' And Secretary of State Marco Rubio, appearing on Fox News Radio, said the U.S. remains 'as committed as ever to our partners ... in places like Taiwan' but also spoke of the strategic need to keep trade ties with China steady. 'In the end, we have two big, the two largest economies in the world,' Rubio said. 'An all-out trade conflict between the U.S. and China, I think the U.S. would benefit from it in some ways, but the world would be hurt by it." There's worry over Taiwan Taiwan is concerned that the self-governing island could be 'trade-able' when Trump seeks a deal with Beijing, said Jason Hsu, a senior fellow at the Hudson Institute and a former legislator in Taiwan. 'Our concern is that, will any of the trade deals lead to concession on political support for Taiwan?" Hsu said, citing the case last month where the White House allegedly blocked a request for Taiwanese President Lai Ching-te to transit through the United States. The U.S. maintains unofficial ties with Taiwan and has always allowed such transits in the past. Experts are worried that the Trump administration is setting a bad precedent, and Democrats have seized on it to criticize Trump. Rep. Raja Krishnamoorthi, the top Democrat on the House Select Committee on China, called the move 'both a sharp break from precedent and another example of the Trump administration caving to China in hopes of reaching a trade deal." He said the policy decision 'sends a dangerous signal' that Taiwan's democracy is negotiable. Hsu said Taiwan fears that Trump could be coerced or compelled to support the one-China principle, as espoused by Beijing, that acknowledges Beijing's sovereignty claim over the island. There are also concerns that Trump might utter anything in support of 'unification." That was a request Beijing raised with the Biden administration, though it failed to get a positive response. Now, it's upon Taiwan to persuade Trump to think of the island as 'an economic partner rather than something that he can trade when he negotiates with China,' Hsu said, suggesting that Taiwan step up defense commitments, increase energy procurement, open its market to U.S. companies and invest more in the U.S. But Sun Yun, director of the China program at the Stimson Center, said Trump is bound by the Taiwan Relations Act, a domestic law that obligates the U.S. to maintain an unofficial relationship with the island and provides it with sufficient hardware to deter any invasion by China. 'He can dial the (U.S.-Taiwan) relationship up and down," Sun said, "but he can't remove the relationship.' Export controls have been instituted, to mixed results In April, the White House, citing national security, announced it would restrict sales of Nvidia's H20 computer chips to China. The ban was lifted about three months later, when the two governments had climbed down from sky-high tariffs and harsh trade restrictions. The decision upset both Republican and Democratic lawmakers. Rep. John Moolenaar, a Michigan Republican who chairs the House Select Committee on China, wrote to Commerce Secretary Howard Lutnick to stress that the U.S. cannot let the Chinese Communist Party 'use American chips to train AI models that will power its military, censor its people, and undercut American innovation.' In Stockholm, Bessent pushed back at the concern that national security might be compromised. 'We are very diligent,' Bessent said, adding there's an interagency process that involves the National Security Council and the Defense Department for decisions. 'There's nothing that's being exchanged for anything,' Bessent said. Addressing H20 chips specifically, Bessent said they 'are well down" Nvidia's "technology chips stack.' U.S. companies are banned from selling their most advanced chips to China. That might not be persuasive enough. Teneo's Wildau said China hawks are most worried that the H20 decision could be the beginning of a series of moves to roll back export controls from the Biden era, which were once considered 'permanent and non-negotiable.'
